Kaposi's sarcoma (KS), the most common neoplasm in AIDS patients, typically presents with multiple skin lesions characterized by "spindle cells", the vast majority of which are infected with KSHV (Kaposi's sarcoma herpes virus, also named HHV-8). In patients with AIDS, the presence of cell-associated KSHV-DNA in blood is predictive of subsequent KS development, but the mechanisms by which circulating KSHV-infected cells contribute to AIDS-KS pathogenesis are unclear. Here we show that the chemokine stromal-derived factor-1 (SDF-1), which is constitutively expressed by skin capillary endothelium and displayed on the endothelial cell surface in association with heparan sulfate, can trigger specific arrest of KSHV-infected cells under physiological shear flow conditions. Moreover, in the presence of soluble SDF-1 gradients, SDF -1 expressed on the endothelial barrier can promote transendothelial migration of KSHV-infected cells.
Introduction
Kaposi's sarcoma (KS), a rare malignancy in the general population, is the most common neoplasm in patients with AIDS. 1 Typically, AIDS-associated KS presents with simultaneous multiple skin lesions that often involve the lower extremities. 2 Less frequently, KS can also arise in lymph nodes, the gastrointestinal mucosa and the lung. 2 Histologically, KS lesions comprise "spindle cells" the majority of which are infected with KSHV (Kaposi's sarcoma herpes virus, also named HHV-8), inflammatory cells and vascular slits. 1, 3 The spindle cells can express markers for smooth-muscle cells, vascular endothelium, macrophages and dendritic cells, suggesting that they are either heterogeneous or represent different stages of differentiation from a pluripotent cell. 4 Recently, spindle cells have been identified belonging to the lymphatic endothelial cell lineage. 5, 6 KSHV, which consistently infects KS lesions, is believed to play an essential role in the pathogenesis of KS through its expression of viral latency genes that directly or indirectly promote cell growth, cytokine and chemokine expression, and angiogenesis. 1, 3, 7 A proportion of HIV-infected individuals harbor in the circulation KSHV-infected cells, which have been identified as B lymphocytes or monocytes. [8] [9] [10] Detection of cellassociated KSHV-DNA in the peripheral blood is predictive of subsequent KS development whereas the detection of free KSHV DNA is not. 8, 11 However, the mechanisms by which circulating cells infected with KSHV contribute to AIDS-KS pathogenesis are currently unclear.
A number of studies have implicated stromal-derived factor-1 (SDF-1), a chemokine produced by stromal cells and other cells in various tissues, [12] [13] [14] [15] [16] as a critical
For personal use only. on . by guest www.bloodjournal.org From 4 regulator of cell recruitment from the blood stream to specific tissues by promoting transendothelial migration through chemokine gradients across the endothelium. Thus, hematopoietic cell movement to and from the bone marrow;
17-24 plasma cell homing to secondary organs and the bone marrow; 25 thymocyte emigration from the thymus; 26 breast cancer cell metastasis to the liver, bone marrow, lymph node; 27 dendritic cell recruitment to ovarian tumors; 28 and melanoma cell localization to the lung 29 have been linked to the interaction between CXCR-4 expressing cells and SDF-1gradients produced in the homing tissue.
Recently, we observed that SDF-1 is constitutively expressed by vascular endothelial cells, and that VEGF (vascular endothelial growth factor) can enhance SDF-1 expression in endothelial cells. 30 Here, we have examined the potential contribution of endothelial cell-associated SDF-1 to the recruitment of KSHV-infected cells from the circulation to sites of KS development. 
Materials and Methods

Cells and cell cultures
Analysis of cell migration under static conditions
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Statistical analysis
The significance of group differences was determined by two-sided, parametric, Student's t test using STATview.
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Results
In patients with AIDS, KS occurs most frequently in the skin, and occasionally in lymph nodes, lung and gastrointestinal tract. constitutively express surface SDF-1 during early passage in culture ( Fig. 2A) , as does the endothelium lining the umbilical vein from which they are derived. 30 Similarly, a proportion (34%) of early passage human dermal microvascular endothelial cells (HDMEC) express surface SDF-1, as does the capillary endothelium in the skin ( Fig.   2A ). (Fig. 2C) . By contrast, the number of K562 cells that arrested remained minimal (Fig 2C) . We also tested the ability of BC-1 cells to arrest, under conditions of physiological shear flow (1.5 dynes/cm 2 ) onto HDMEC, which like HUVEC display surface SDF-1 ( Fig. 2A) . As shown (Fig. 2D) This process is dependent upon the presence of surface SDF-1 on the endothelium and signaling through a G i -protein-coupled receptor in the arresting B cells.
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An in vitro transendothelial migration assay using a monolayer of SDF-1-expressing HUVEC or HDMEC was used to assess whether cells arrested onto SDF-1-bearing endothelium would transmigrate across the endothelial barrier. In the absence of a soluble SDF-1 gradient across the HUVEC barrier, minimal cell transmigration was observed with BC-1 and BL-41 cells (Fig. 3A) . In the presence of soluble SDF-1 (100 ng/ml) across the HUVEC barrier, BC-1 and BL-41 cell transmigration was markedly enhanced (p<0.05, Fig. 3A) . Similar results were obtained for BC-1 cell transmigration across a monolayer of SDF-1 expressing HDMEC cells (Fig. 3B) . Treatment of the HUVEC endothelial cell barrier with heparinase III prior to addition of BC-1or BL-41 cells to the upper chamber reduced significantly (p<0.05) cell transmigration (Fig. 3A) . To further evaluate the contribution of cell-associated SDF-1, we compared cell transmigration across endothelial monolayers that differ in the levels of cell associated SDF-1 they express. Early-passage (passage 2-4) HUVEC express surface SDF-1 whereas HUVEC from a later passage (passage 18) do not (Fig. 3C) Here we show that surface SDF-1 constitutively expressed by selected vascular endothelium can promote specific arrest and trans-endothelial migration of cells that human tissues has revealed that the skin has higher levels of expression compared to muscle and brain. 27 Once established, KS lesions expressing high levels SDF-1could
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